POLITICO.eu·3 min read·medium
UK approves its second weight-loss pill while EU access lags - politico.eu
H
Helen Collis
✦AI Summary
The U.K. has become the first European regulator to approve Eli Lilly's oral weight-loss pill, Foundayo, for weight management and type 2 diabetes. While the drug is now licensed, access through the National Health Service remains pending a decision in November.
A decision on whether Britain’s National Health Service will cover the drug is expected in November.
healthbusiness
✦
Get the full story
Sign up for Headlinne to unlock AI insights, political bias analysis, and your personalized news feed.
Create free accountAlready have an account? Sign in